Company Overview
Bittium is a Finnish technology company specializing in defense, security, and medical solutions. With over 500 employees across three continents, Bittium has established itself as a leading provider of innovative products and services to various industries. The company's primary mission is to deliver cutting-edge technologies that enhance the safety and well-being of people worldwide. At its core, Bittium values innovation, customer satisfaction, and responsible business practices. By embracing these principles, Bittium aims to become a trusted partner for organizations seeking to improve their performance and competitiveness.
Key Products/Services
Bittium offers a range of products and services that cater to the needs of various industries, including defense, security, medical, and industrial sectors. Some of its key offerings include:
- Long-lasting and secure communication and data transfer solutions
- Advanced remote healthcare diagnostic solutions
- Product development services
- 5G phones and secure mobile
Bittium's products and services are designed to provide customers with innovative solutions that enhance their performance, efficiency, and safety. By leveraging its expertise in advanced technologies, Bittium helps organizations stay ahead of the competition and address complex challenges.
Benefits
The benefits of investing in Bittium's products and services include:
- Improved safety and well-being through innovative solutions
- Enhanced performance and efficiency in various industries
- Access to cutting-edge technologies and expertise
- Strong customer satisfaction and support
By investing in Bittium, you can tap into the company's expertise and innovative solutions to drive growth, improve performance, and stay ahead of the competition.
Valuation
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Number of Shares (million) | 35.7 | 35.7 | 35.5 | 35.7 | 35.7 | 35.7 | 35.7 |
| Target Valuation (MEur) | 67.6 | 67.8 | 58.6 | 63.1 | 87.7 | 100.6 | 100.6 |
| Target Price | 1.89 | 1.9 | 1.65 | 1.77 | 2.46 | 2.82 | 2.82 |
| Potential, % | -52.4 | -60.5 | -74.0 | -94.1 | -93.2 | -92.2 | -92.2 |
| Recommendation | Sell | Sell | Sell | Sell | Sell | Sell | Sell |
| MCAP (MEur) | 141.9 | 171.7 | 225.7 | 1069.3 | 1297.8 | 1297.8 | 1297.8 |
| Price | 3.97 | 4.81 | 6.36 | 29.95 | 36.35 | 36.35 | 36.35 |
| EV | 145.0 | 186.0 | 225.0 | 1068.0 | 1262.0 | 1244.0 | 1235.0 |
| P/S | 1.72 | 2.28 | 2.65 | 8.97 | 8.23 | 8.18 | 9.02 |
| EV/S | 1.76 | 2.47 | 2.64 | 8.96 | 8.0 | 7.84 | 8.59 |
| EV/EBIT | 484.38 | -43.24 | 26.15 | 55.06 | 42.99 | 54.87 | 80.25 |
| P/E | 473.05 | -31.8 | 30.92 | 50.2 | 55.91 | 71.54 | 105.34 |
| P/B | 1.23 | 1.6 | 2.0 | 8.17 | 8.77 | 7.82 | 7.28 |
| P/OCF | 17.74 | 143.11 | 9.25 | 69.89 | 26.57 | 50.65 | 74.37 |
| EV/OCF | 18.16 | 154.94 | 9.22 | 69.82 | 25.84 | 48.57 | 70.78 |
| P/FCF | 1.5978259193452906e+17 | -26.42 | 12.75 | 227.51 | 32.01 | 73.65 | 137.33 |
| EV/FCF | 1.63610651617794e+17 | -28.6 | 12.71 | 227.28 | 31.13 | 70.63 | 130.69 |
Income Statement
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Revenue | 82.5 | 75.2 | 85.1 | 119.2 | 157.7 | 158.6 | 143.8 |
| Rev. Growth, % | -5.1 | -8.8 | 13.2 | 40.1 | 32.3 | 0.6 | -9.3 |
| Ebit | 0.3 | -4.3 | 8.6 | 19.4 | 29.4 | 22.7 | 15.4 |
| Ebit Growth, % | -90.6 | -1533.3 | 300.0 | 125.6 | 51.5 | -22.8 | -32.2 |
| Ebit, % | 0.4 | -5.7 | 10.1 | 16.3 | 18.6 | 14.3 | 10.7 |
| Profit | 0.3 | -5.4 | 7.3 | 21.3 | 23.2 | 18.1 | 12.3 |
| EPS | 0.01 | -0.15 | 0.21 | 0.6 | 0.65 | 0.51 | 0.34 |
| Profit Growth, % | -90.9 | -1900.0 | 235.2 | 191.8 | 8.9 | -22.0 | -32.0 |
| Profit, % | 0.4 | -7.2 | 8.6 | 17.9 | 14.7 | 11.4 | 8.6 |
Balance Sheet
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Inventory | 24.2 | 26.6 | 24.8 | 24.4 | 28.5 | 32.8 | 34.5 |
| Acc. Receivable | 41.4 | 38.1 | 35.8 | 61.6 | 44.7 | 44.6 | 44.2 |
| Cash | 19.0 | 8.3 | 21.8 | 20.9 | 54.4 | 72.1 | 81.5 |
| Equity | 115.8 | 107.6 | 112.8 | 130.8 | 147.9 | 166.1 | 178.4 |
| ROE, % | 0.3 | -5.0 | 6.5 | 16.3 | 15.7 | 10.9 | 6.9 |
| ROCE, % | 0.2 | -3.3 | 6.4 | 12.9 | 17.6 | 12.3 | 7.8 |
| Net Debt | 3.4 | 14.2 | -0.8 | -1.0 | -35.7 | -53.3 | -62.7 |
| Gearing, % | 2.9 | 13.2 | -0.7 | -0.8 | -24.1 | -32.1 | -35.2 |
| Equity ratio, % | 68.2 | 68.2 | 68.3 | 68.7 | 72.1 | 77.8 | 79.7 |
| Acc. Payable | 26.4 | 22.4 | 25.6 | 33.9 | 44.2 | 41.6 | 37.6 |
| Total Assets | 169.7 | 157.7 | 165.1 | 190.4 | 205.0 | 213.4 | 223.7 |
| ROA, % | 0.2 | -3.4 | 4.4 | 11.2 | 11.3 | 8.5 | 5.5 |
Cash Flow
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.0 | 1.2 | 24.4 | 15.3 | 48.8 | 25.6 | 17.4 |
| Investment Cash Flow | -8.0 | -7.7 | -6.7 | -10.6 | -8.3 | -8.0 | -8.0 |
| Free Cash Flow | 0.0 | -6.5 | 17.7 | 4.7 | 40.5 | 17.6 | 9.4 |
| OCF/CAPEX | 1.0 | 0.16 | 3.64 | 1.44 | 5.88 | 3.2 | 2.18 |
| Financial Cash Flow | -3.0 | -4.2 | -4.3 | -5.6 | -6.9 | 0.0 | 0.0 |
Disclaimer
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
The data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.
Contact: quant@quantfactory.eu